Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Critical Care
    • Dexmedetomidine...

    Dexmedetomidine Infusion effectively controls pain during Laparoscopic Cholecystectomy

    Written by Vinay Singh singh Published On 2018-05-18T19:31:15+05:30  |  Updated On 18 May 2018 7:31 PM IST
    Dexmedetomidine Infusion effectively controls pain during Laparoscopic Cholecystectomy

    Intraoperative DEX infusion is safe and effective for improving analgesia during and after laparoscopic cholecystectomy(LC), says study. Kateryna Beilka conducted the study to evaluate the efficacy and safety of DEX infusion during elective laparoscopic cholecystectomy (LC) the results of which appear in the journal BMC Anesthesiology.


    Laparoscopic cholecystectomy is usually associated with less pain compared with an open surgery but the postoperative pain still remains the matter of concern after LC which often prolongs hospital stay. Moderate abdominal and shoulder pain is experienced by 36–63% of patients 24–48 h after LC and up to 13% of patients experience severe pain.


    Dexmedetomidine (DEX) has sedative, sympatholytic and analgesic effects and is beneficial if used as an adjuvant to improve analgesia, modulate hemodynamic responses to intubation and pneumoperitoneum and reduce the number of opioid-associated adverse events.


    A randomized, single-centre, parallel-group, placebo-controlled study was carried out on adult patients (18–79 years) who were randomly assigned to 0.5 μg/kg/h DEX infusion from induction of anaesthesia to extubation or normal saline infusion. The primary efficacy outcomes were postoperative morphine consumption. Secondary efficacy outcomes included time to first use of rescue analgesia, postoperative morphine consumption, intraoperative fentanyl consumption,time from end of surgery to extubation,lengths of intensive care unit (ICU) and general ward stay,degree of postoperative pain 3, 6, 12 and 24 h after surgery and incidence of persistent post-surgical pain.


    The study found that DEX infusion was associated with a decrease in postoperative morphine consumption, lower incidence of severe postoperative pain and significantly longer time to first use of rescue analgesia.


    The study concluded that intraoperative DEX infusion is safe and effective for improving analgesia during and after laparoscopic cholecystectomy and reduces the number of patients with severe postoperative pain, and postoperative morphine consumption.


    The study was published in the journal BMC Anesthesiology

    For more reference log on to https://doi.org/10.1186/s12871-018-0508-6

    BMC AnesthesiologyCholecystectomyDEXextubationfentanylinfusionintraoperativeLaparoscopicmorphinePainpneumoperitoneumpost surgicalPostoperativerescueshouldersympatholytic
    Source : With inputs from the journal BMC�Anesthesiology

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Vinay Singh singh
    Vinay Singh singh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok